| Acquired factor VIII inhibitor presenting as a tongue hematoma. | |
| | |
MedLine Citation:
|
PMID: 15093846 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Acquired hemophilia is a rare disorder that has potentially disastrous consequences if not recognized and treated in the setting of acute hemorrhage. We report a case of undiagnosed acquired hemophilia due to factor VIII inhibitor in which a tongue hematoma was the chief manifestation. Diagnosis, acute management, and long-term therapeutic options are reviewed. |
| | |
Authors:
|
Catherine M Wendell; Marc A Bellazzini; David S Howes |
Related Documents
:
|
23042846 - The history of dengue outbreaks in the americas. 23597216 - Natal and neonatal teeth: a systematic review of prevalence and management. 3513296 - The value of routine sonography in clinically suspected acute cholecystitis. 11873106 - Constrictive pericarditis in chronic ulcerative colitis. 498836 - Primary pulmonary hypertension. responses to indomethacin, terbutaline, and isoproterenol. 10761356 - Case study: bipolar disorder after head injury. |
Publication Detail:
|
Type: Case Reports; Journal Article |
Journal Detail:
|
Title: The Journal of emergency medicine Volume: 26 ISSN: 0736-4679 ISO Abbreviation: J Emerg Med Publication Date: 2004 May |
Date Detail:
|
Created Date: 2004-04-19 Completed Date: 2004-07-28 Revised Date: 2004-11-17 |
Medline Journal Info:
|
Nlm Unique ID: 8412174 Medline TA: J Emerg Med Country: United States |
Other Details:
|
Languages: eng Pagination: 411-4 Citation Subset: IM |
Affiliation:
|
Section of Emergency Medicine, University of Chicago, Chicago, Illinois, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Aged Blood Coagulation Factors / therapeutic use Factor VIII / antagonists & inhibitors* Female Hematoma / etiology* Hemophilia A / complications*, drug therapy Humans Partial Thromboplastin Time Tongue Diseases / etiology* |
| Chemical | |
Reg. No./Substance:
|
0/Blood Coagulation Factors; 37224-63-8/prothrombin complex concentrates; 9001-27-8/Factor VIII |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Antipyretic effectiveness of intravenous ketorolac tromethamine.
Next Document: SARS and its impact on current and future Emergency Department operations.